Agilent Technologies, Inc. (NYSE:A) Shares Bought by Metis Global Partners LLC

Metis Global Partners LLC increased its stake in Agilent Technologies, Inc. (NYSE:A) by 3.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,197 shares of the medical research company’s stock after buying an additional 562 shares during the quarter. Metis Global Partners LLC’s holdings in Agilent Technologies were worth $2,256,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the business. Curi RMB Capital LLC increased its holdings in shares of Agilent Technologies by 11.4% in the 3rd quarter. Curi RMB Capital LLC now owns 5,606 shares of the medical research company’s stock worth $832,000 after acquiring an additional 574 shares during the period. Cable Hill Partners LLC acquired a new position in Agilent Technologies in the third quarter worth approximately $211,000. Kovack Advisors Inc. purchased a new position in shares of Agilent Technologies during the third quarter valued at $270,000. Oppenheimer Asset Management Inc. boosted its stake in Agilent Technologies by 1.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 45,931 shares of the medical research company’s stock valued at $6,820,000 after purchasing an additional 658 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Agilent Technologies by 1.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 663,767 shares of the medical research company’s stock valued at $98,556,000 after acquiring an additional 9,703 shares during the period.

Wall Street Analyst Weigh In

Several analysts have commented on A shares. Barclays upped their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. TD Cowen raised their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. UBS Group lifted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Finally, Evercore ISI boosted their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $144.36.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The trade was a 7.51 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. The trade was a 19.98 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 11,995 shares of company stock valued at $1,739,510.

Agilent Technologies Stock Down 2.4 %

A stock opened at $127.07 on Friday. The firm has a market cap of $36.51 billion, a PE ratio of 26.36, a P/E/G ratio of 5.91 and a beta of 1.07. The firm’s fifty day moving average is $138.93 and its 200 day moving average is $138.08. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. Agilent Technologies, Inc. has a one year low of $112.06 and a one year high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company’s quarterly revenue was down 5.6% on a year-over-year basis. During the same period last year, the business posted $1.43 earnings per share. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 19.50%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.